Cargando…
Should Patients with Hidradenitis Suppurativa Undergo LASIK?
ABSTRACT: Hidradenitis suppurativa (HS) is a relatively common chronic inflammatory disease with immune dysregulation. While eye manifestations of HS are rare, a dilemma arises when these patients seek treatment for refractive errors. Although excimer laser surgery can be safely performed in patient...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692419/ https://www.ncbi.nlm.nih.gov/pubmed/31313219 http://dx.doi.org/10.1007/s40123-019-0201-y |
_version_ | 1783443548091187200 |
---|---|
author | Rosen, David B. Moshirfar, Majid Heiland, Madeline B. Ronquillo, Yasmyne C. Hoopes, Phillip C. |
author_facet | Rosen, David B. Moshirfar, Majid Heiland, Madeline B. Ronquillo, Yasmyne C. Hoopes, Phillip C. |
author_sort | Rosen, David B. |
collection | PubMed |
description | ABSTRACT: Hidradenitis suppurativa (HS) is a relatively common chronic inflammatory disease with immune dysregulation. While eye manifestations of HS are rare, a dilemma arises when these patients seek treatment for refractive errors. Although excimer laser surgery can be safely performed in patients with autoimmune and immune-mediated inflammatory disease, there are caveats. Aside from the routine laser-assisted in situ keratomileusis (LASIK) screening tests, in some instances, we recommend additional screening tests in patients with HS, such as dry eye tests, consultation with specialists regarding HS diagnosis and treatment, careful assessment of the eyelids and periorbital structures, and thorough history of past and current lesions and treatments. After these patients undergo LASIK, careful, frequent, and long-term follow-up is necessary. Any adverse event or complication should be managed immediately. FUNDING: Research to Prevent Blindness funded the study. Hoopes Vision funded the Rapid Service Fees. |
format | Online Article Text |
id | pubmed-6692419 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-66924192019-08-26 Should Patients with Hidradenitis Suppurativa Undergo LASIK? Rosen, David B. Moshirfar, Majid Heiland, Madeline B. Ronquillo, Yasmyne C. Hoopes, Phillip C. Ophthalmol Ther Commentary ABSTRACT: Hidradenitis suppurativa (HS) is a relatively common chronic inflammatory disease with immune dysregulation. While eye manifestations of HS are rare, a dilemma arises when these patients seek treatment for refractive errors. Although excimer laser surgery can be safely performed in patients with autoimmune and immune-mediated inflammatory disease, there are caveats. Aside from the routine laser-assisted in situ keratomileusis (LASIK) screening tests, in some instances, we recommend additional screening tests in patients with HS, such as dry eye tests, consultation with specialists regarding HS diagnosis and treatment, careful assessment of the eyelids and periorbital structures, and thorough history of past and current lesions and treatments. After these patients undergo LASIK, careful, frequent, and long-term follow-up is necessary. Any adverse event or complication should be managed immediately. FUNDING: Research to Prevent Blindness funded the study. Hoopes Vision funded the Rapid Service Fees. Springer Healthcare 2019-07-16 2019-09 /pmc/articles/PMC6692419/ /pubmed/31313219 http://dx.doi.org/10.1007/s40123-019-0201-y Text en © The Author(s) 2019 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Commentary Rosen, David B. Moshirfar, Majid Heiland, Madeline B. Ronquillo, Yasmyne C. Hoopes, Phillip C. Should Patients with Hidradenitis Suppurativa Undergo LASIK? |
title | Should Patients with Hidradenitis Suppurativa Undergo LASIK? |
title_full | Should Patients with Hidradenitis Suppurativa Undergo LASIK? |
title_fullStr | Should Patients with Hidradenitis Suppurativa Undergo LASIK? |
title_full_unstemmed | Should Patients with Hidradenitis Suppurativa Undergo LASIK? |
title_short | Should Patients with Hidradenitis Suppurativa Undergo LASIK? |
title_sort | should patients with hidradenitis suppurativa undergo lasik? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692419/ https://www.ncbi.nlm.nih.gov/pubmed/31313219 http://dx.doi.org/10.1007/s40123-019-0201-y |
work_keys_str_mv | AT rosendavidb shouldpatientswithhidradenitissuppurativaundergolasik AT moshirfarmajid shouldpatientswithhidradenitissuppurativaundergolasik AT heilandmadelineb shouldpatientswithhidradenitissuppurativaundergolasik AT ronquilloyasmynec shouldpatientswithhidradenitissuppurativaundergolasik AT hoopesphillipc shouldpatientswithhidradenitissuppurativaundergolasik |